Search

Displaying results 4861 - 4870 of 5363 in total
  1. Drug

    Pirifibrate

    go.drugbank.com/drugs/DB20620
    Experimental

    Pirifibrate has a monoisotopic molecular weight of 335.09 Da.

  2. Drug

    Salafibrate

    go.drugbank.com/drugs/DB20767
    Experimental

    Salafibrate has a monoisotopic molecular weight of 646.14 Da.

  3. Drug

    Elarofiban anhydrous

    go.drugbank.com/drugs/DB21212
    Experimental

    Elarofiban anhydrous has a monoisotopic molecular weight of 416.24 Da.

  4. Drug

    Atigliflozin

    go.drugbank.com/drugs/DB21394
    Investigational

    Atigliflozin has a monoisotopic molecular weight of 382.11 Da.

  5. Drug

    Lifibrate

    go.drugbank.com/drugs/DB21399
    Experimental

    Lifibrate has a monoisotopic molecular weight of 409.08 Da.

  6. Drug

    Dazdotuftide

    go.drugbank.com/drugs/DB21550
    Investigational

    Dazdotuftide has a monoisotopic molecular weight of 1005.48 Da.

  7. Drug

    Muvalaplin

    go.drugbank.com/drugs/DB21568
    Investigational

    Muvalaplin has a monoisotopic molecular weight of 710.4 Da.

  8. Drug

    Pocenbrodib

    go.drugbank.com/drugs/DB21616
    Investigational

    Pocenbrodib has a monoisotopic molecular weight of 525.23 Da.

  9. Drug

    Upleganan

    go.drugbank.com/drugs/DB21618
    Investigational

    Upleganan has a monoisotopic molecular weight of 1143.6 Da.

  10. Drug

    Levamisole

    go.drugbank.com/drugs/DB00848
    ApprovedInvestigationalVet approvedWithdrawn

    [A178117, A178123] Levamisole was withdrawn from the American market in 2000 due to its ability to cause serious adverse effects, including agranulocytosis.